| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018058432 |
| P356 | DOI | 10.1093/JURBAN/JTI049 |
| P932 | PMC publication ID | 3456573 |
| P698 | PubMed publication ID | 15872194 |
| P5875 | ResearchGate publication ID | 7866772 |
| P50 | author | Serge Brochu | Q39774045 |
| Mark W. Tyndall | Q51002222 | ||
| Suzanne Brissette | Q58206511 | ||
| Jürgen Rehm | Q59708828 | ||
| P2093 | author name string | Julie Bruneau | |
| Benedikt Fischer | |||
| Dolly Baliunas | |||
| Nady El-Guebaly | |||
| Cameron Wild | |||
| Lina Noël | |||
| Phil Mun | |||
| P2860 | cites work | The self-medication hypothesis of substance use disorders: a reconsideration and recent applications | Q28255574 |
| Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection | Q28361460 | ||
| Selected major risk factors and global and regional burden of disease | Q29614888 | ||
| The world health report 2002 - reducing risks, promoting healthy life | Q29615448 | ||
| The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 | ||
| Methadone treatment in Ontario after the 1996 regulation reforms. Results of a physician survey. | Q33185642 | ||
| Approaches to treatment decisions for psychiatric comorbidity in the management of the chronic pain patient | Q33673583 | ||
| Methadone maintenance treatment (MMT): a review of historical and clinical issues | Q33924363 | ||
| Injection drug use and preventive measures: a comparison of Canadian and western European jurisdictions over time | Q34038002 | ||
| Current status of hepatitis C in Canada. | Q34073858 | ||
| Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study | Q34101461 | ||
| Heroin overdose: causes and consequences | Q34327207 | ||
| Fatal heroin 'overdose': a review | Q34413531 | ||
| Needle exchange is not enough: lessons from the Vancouver injecting drug use study | Q34432600 | ||
| Medication misuse, abuse and dependence in chronic pain patients | Q34448794 | ||
| Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? | Q34795087 | ||
| Heroin-assisted treatment as a response to the public health problem of opiate dependence. | Q34859986 | ||
| Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients | Q35024272 | ||
| Appropriateness of methadone maintenance treatment for opiate addiction: evaluation by an expert panel. | Q35189152 | ||
| First use of heroin: changes in route of administration over time | Q35821084 | ||
| The social determinants of emergency department and hospital use by injection drug users in Canada | Q36274713 | ||
| Social costs of untreated opioid dependence | Q36274931 | ||
| Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. | Q37343391 | ||
| Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. | Q39383296 | ||
| Syringe exchange in Canada: good but not enough to stem the HIV tide | Q39467633 | ||
| Methadone maintenance treatment: An update | Q40470835 | ||
| Role of maintenance treatment in opioid dependence | Q40826831 | ||
| Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. | Q41040479 | ||
| Accuracy of Oral Specimen Testing for Human Immunodeficiency Virus | Q41526249 | ||
| The case for a heroin substitution treatment trial in Canada. | Q41698241 | ||
| HIV and hepatitis C among injecting drug users | Q42757973 | ||
| Assessment of a hepatitis C virus antibody assay in saliva for epidemiological studies | Q42990676 | ||
| Evaluation of hepatitis C antibody testing in saliva specimens collected by two different systems in comparison with HCV antibody and HCV RNA in serum | Q43030763 | ||
| The heroin prescribing debate: integrating science and politics. | Q43592853 | ||
| Prescriptions, power and politics: the turbulent history of methadone maintenance in Canada. | Q43749199 | ||
| Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users | Q43762591 | ||
| Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors | Q43824699 | ||
| HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme | Q43839370 | ||
| Changing patient characteristics with increased methadone maintenance availability | Q43890375 | ||
| Canadian illicit opiate users' views on methadone and other opiate prescription treatment: an exploratory qualitative study. | Q44027634 | ||
| Continuing HIV transmission among injection drug users in Eastern Central Canada: the SurvUDI Study, 1995 to 2000. | Q44087372 | ||
| Psychiatric and substance use comorbidity among treatment-seeking opioid abusers | Q44235913 | ||
| Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up | Q44349134 | ||
| Decline in intravenous drug use among treatment-seeking opiate users | Q44547953 | ||
| Evaluation of an HIV saliva test for the detection of HIV-1 and HIV-2 antibodies in high-risk populations in Abidjan, Côte d'Ivoire | Q46610577 | ||
| Psychiatric comorbidity in opiate addicts. | Q51983545 | ||
| Performance of the Composite International Diagnostic Interview Short Form for major depression in community and clinical samples. | Q52004537 | ||
| Methadone maintenance: predictors of outcome in a Canadian milieu. | Q52273491 | ||
| A long-term program of research on drug use and crime. | Q52276287 | ||
| Trends in treated opiate misuse in Dublin: the emergence of chasing the dragon. | Q52279138 | ||
| Client retention in the British Columbia Methadone Program, 1996-1999. | Q52286060 | ||
| Continuing drug risk behaviour: shared use of injecting paraphernalia among London heroin injectors. | Q52308293 | ||
| Polydrug dependence and psychiatric comorbidity among heroin injectors. | Q53357261 | ||
| Consideration of a North American heroin-assisted clinical trial for the treatment of opiate-dependent individuals. | Q54038734 | ||
| Predictors and Prevention of Nonfatal Overdose Among Street-Recruited Injection Heroin Users in the San Francisco Bay Area, 1998–1999 | Q56594744 | ||
| Crime and drug use among applicants for methadone maintenance | Q70567080 | ||
| Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity | Q71725061 | ||
| Response to methadone maintenance and counseling in antisocial patients with and without major depression | Q71861241 | ||
| [Accessibility to methadone substitution treatment: the role of a low-threshold program] | Q73488013 | ||
| Drug-related deaths among recently released prisoners in the Strathclyde Region of Scotland | Q73900632 | ||
| High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study | Q74010685 | ||
| Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction | Q77675795 | ||
| P433 | issue | 2 | |
| P921 | main subject | Canada | Q16 |
| opioid | Q427523 | ||
| P304 | page(s) | 250-266 | |
| P577 | publication date | 2005-05-04 | |
| P1433 | published in | Journal of Urban Health | Q15760615 |
| P1476 | title | Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). | |
| P478 | volume | 82 |
| Q92667693 | A Canadian perspective on the developmental origins of health and disease: understanding the past as a way forward |
| Q36960510 | A qualitative exploration of prescription opioid injection among street-based drug users in Toronto: behaviours, preferences and drug availability |
| Q36882045 | Acute and chronic respiratory symptoms among primary care patients who smoke crack cocaine |
| Q38625466 | Adverse outcomes associated with opioid prescription for acute low back pain: a systematic review protocol |
| Q43458058 | Alcohol-attributable mortality and years of potential life lost in Chile in 2009. |
| Q36105291 | Association between cannabis use and treatment outcomes in patients receiving methadone maintenance treatment: a systematic review protocol |
| Q43204618 | Changes in illicit opioid use across Canada |
| Q35320110 | Changes in somatic disease incidents during opioid maintenance treatment: results from a Norwegian cohort study |
| Q37067411 | Changing patterns in opioid addiction: characterizing users of oxycodone and other opioids. |
| Q52317831 | Characterizing Mortality from Substance Abuse in Iran: An Epidemiological Study during March 2014 to February 2015. |
| Q44332019 | Comparing injecting and non-injecting illicit opioid users in a multisite Canadian sample (OPICAN Cohort). |
| Q33560028 | Controlling chaos: the perceptions of long-term crack cocaine users in vancouver, british columbia, Canada. |
| Q35231536 | Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City |
| Q39777878 | Crack across Canada: Comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users |
| Q46506734 | Crack use as a public health problem in Canada: call for an evaluation of 'safer crack use kits'. |
| Q37438987 | Days of heroin use predict poor self-reported health in hospitalized heroin users |
| Q37872347 | Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours |
| Q44340153 | Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario. |
| Q39775956 | Drug-related overdose deaths in British Columbia and Ontario, 1992-2004. |
| Q37786349 | Elevated overdose mortality rates among First Nations individuals in a Canadian setting: a population-based analysis |
| Q33560231 | Evaluation of a low-threshold/high-tolerance methadone maintenance treatment clinic in saint john, new brunswick, Canada: one year retention rate and illicit drug use |
| Q44336641 | Factors Associated with Perceived Abuse in the Health Care System Among Long-Term Opioid Users: A Cross-Sectional Study |
| Q37255520 | Gender and comorbidity among individuals with opioid use disorders in the NESARC study |
| Q34139876 | Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence |
| Q39761570 | Health and social services accessed by a cohort of Canadian illicit opioid users outside of treatment |
| Q51908256 | Hepatitis C, illicit drug use and public health: does Canada really have a viable plan? |
| Q39904425 | How many people in Canada use prescription opioids non-medically in general and street drug using populations? |
| Q60308233 | Identifying patient-important outcomes in medication-assisted treatment for opioid use disorder patients: a systematic review protocol |
| Q36628467 | Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). |
| Q30818319 | Impact of a methadone maintenance program on an Aboriginal community: a qualitative study |
| Q35127554 | Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility. |
| Q43036078 | Incidence and risk factors for newly acquired hepatitis C virus infection among Aboriginal versus non-Aboriginal Canadians in six regions, 1999-2004. |
| Q36089748 | Increases in the availability of prescribed opioids in a Canadian setting |
| Q37230564 | Integrated care for pregnant women on methadone maintenance treatment: Canadian primary care cohort study |
| Q33716359 | Key challenges in providing services to people who use drugs: The perspectives of people working in emergency departments and shelters in Atlantic Canada |
| Q36139072 | Monitoring Utilization of a Large Scale Addiction Treatment System: The Drug and Alcohol Treatment Information System (DATIS). |
| Q34023781 | Negotiating the Relationship Between Addiction, Ethics, and Brain Science |
| Q37923987 | Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review |
| Q36301817 | Opioid dependence latent structure: two classes with differing severity? |
| Q58234274 | Penser et percevoir autrement les personnes qui font usage de drogues par injection |
| Q48013189 | Perceived unmet need and barriers to care amongst street-involved people who use illicit drugs. |
| Q46769024 | Physical illness in psychiatric inpatients: comparison of patients with and without substance use disorders |
| Q35012581 | Policy makers ignoring science and scientists ignoring policy: the medical ethical challenges of heroin treatment |
| Q44226038 | Prevalence and associated factors of hepatitis C infection (HCV) in a multi-site Canadian population of illicit opioid and other drug users (OPICAN). |
| Q40069341 | Profiles of illicit drug use during annual key holiday and control periods in Australia: wastewater analysis in an urban, a semi-rural and a vacation area. |
| Q45130692 | Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making |
| Q64253458 | Qualitative exploration of the education and skill needs of community pharmacists in Saskatoon concerning substance use disorder |
| Q37193780 | Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report |
| Q37394050 | Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. |
| Q44851144 | Socio-economic determinants of drugged driving--a register-based study |
| Q33317649 | Somatic health among heroin addicts before and during opioid maintenance treatment: a retrospective cohort study |
| Q36984245 | Spatial patterns of arrests, police assault and addiction treatment center locations in Tijuana, Mexico |
| Q90419454 | The Discrimination Against, Health Status and Wellness of People Who Use Drugs in Italian Services: A Survey |
| Q36985312 | The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment. |
| Q36033587 | The role of living context in prescription opioid injection and the associated risk of hepatitis C infection. |
| Q47712857 | Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol |
| Q33877419 | Wide variation in the multiplicity of HIV-1 infection among injection drug users |
| Q52288329 | [Willing to undergo hepatitis C treatment in a sample of injection drug users in Toronto, Canada]. |
Search more.